Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Oct;21(5):466-71.
doi: 10.1016/j.coi.2009.07.003. Epub 2009 Aug 3.

Genetics of hypogammaglobulinemia: what do we really know?

Affiliations
Review

Genetics of hypogammaglobulinemia: what do we really know?

Mary Ellen Conley. Curr Opin Immunol. 2009 Oct.

Abstract

In the past, immunodeficiencies were categorized based on clinical and laboratory findings in the affected patient. Now we are more likely to define them based on the specific gene involved. One might expect this shift to increase the precision and clarity of diagnosis but in the last few years it has become increasingly clear that identification of a mutation in a specific gene may not tell the whole story. Some gene defects may reliably result in clinical disease, others may act as susceptibility factors that are more common in patients with immunodeficiency but can also be found in otherwise healthy individuals. Distinguishing between these two types of gene defects is essential for informative genetic counseling.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
The pie diagram shows the percentage of patients with early defects in B cell development who have mutations in each of the genes shown. These are patients with the early onset of recurrent infections, severe hypogammaglobulinemia and absent or markedly reduced numbers of circulating B cells, but no other medical problems.
Fig. 2
Fig. 2
This pie diagram shows the percentage of patients with CVID who have a family history of immunodeficiency or who have a known genetic defect.

References

    1. Durandy A, Taubenheim N, Peron S, Fischer A. Pathophysiology of B-cell intrinsic immunoglobulin class switch recombination deficiencies. Adv.Immunol. 2007;94:275–306. This review provides an excellent overview of genes involved in the various forms of hyper-IgM syndrome including AICDA (AID) and UNG. It addresses the role of these genes in class switch recombination and somatic hypermutation. - PubMed
    1. Dobbs AK, Yang T, Farmer D, Kager L, Parolini O, Conley ME. A hypomorphic mutation in Igbeta (CD79b) in a patient with immunodeficiency and a leaky defect in B cell development. J.Immunol. 2007;179:2055–2059. This paper and Ref 10 are the first descriptions of mutations in Igβ (CD79b), a transmembrane component of the B cell antigen receptor. The patients described in both papers had agammaglobulinemia; however the mutation reported in this paper is a hypomorphic mutation and the patient had a leaky defect in B cell development whereas the patient reported in Ref. 10 had a null mutation and a complete block in B cell development. - PubMed
    1. Conley ME, Farmer DM, Dobbs AK, Howard V, Aiba Y, Shurtleff SA, Kurosaki T. A minimally hypomorphic mutation in Btk resulting in reduced B cell numbers but no clinical disease. Clin.Exp.Immunol. 2008;152:39–44. - PMC - PubMed
    1. Devriendt K, Kim AS, Mathijs G, Frints SG, Schwartz M, Van Den Oord JJ, Verhoef GE, Boogaerts MA, Fryns JP, You D, et al. Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia. Nat.Genet. 2001;27:313–317. - PubMed
    1. Ancliff PJ, Blundell MP, Cory GO, Calle Y, Worth A, Kempski H, Burns S, Jones GE, Sinclair J, Kinnon C, et al. Two novel activating mutations in the Wiskott-Aldrich syndrome protein result in congenital neutropenia. Blood. 2006;108:2182–2189. - PubMed

MeSH terms

Substances